FOXD2 and central nervous system cancer: In summary, our study concluded that silencing FOXD2-AS1 upregulated miR-98-5p and decreased CPEB4, thus obviously inhibiting the proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promoting their apoptosis.